Virtu Financial’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $255K | Buy |
+205,780
| New | +$255K | 0.01% | 821 |
|
|
2024
Q4 | – | Sell |
-27,752
| Closed | -$47K | – | 1916 |
|
|
2024
Q3 | $47K | Sell |
27,752
-35,242
| -56% | -$59.7K | ﹤0.01% | 1021 |
|
|
2024
Q2 | $86K | Buy |
+62,994
| New | +$86K | 0.01% | 843 |
|
|
2024
Q1 | – | Sell |
-18,047
| Closed | -$177K | – | 1912 |
|
|
2023
Q4 | $177K | Buy |
+18,047
| New | +$177K | 0.01% | 875 |
|
|
2022
Q3 | – | Sell |
-29,436
| Closed | -$130K | – | 2103 |
|
|
2022
Q2 | $130K | Sell |
29,436
-3,177
| -10% | -$14K | 0.01% | 877 |
|
|
2022
Q1 | $297K | Buy |
32,613
+10,133
| +45% | +$92.3K | 0.02% | 589 |
|
|
2021
Q4 | $460K | Sell |
22,480
-978
| -4% | -$20K | 0.05% | 406 |
|
|
2021
Q3 | $599K | Buy |
+23,458
| New | +$599K | 0.05% | 385 |
|
|
2020
Q4 | – | Sell |
-36,080
| Closed | -$356K | – | 1701 |
|
|
2020
Q3 | $356K | Buy |
36,080
+25,803
| +251% | +$255K | 0.06% | 377 |
|
|
2020
Q2 | $35K | Buy |
+10,277
| New | +$35K | ﹤0.01% | 1056 |
|
|
2018
Q2 | – | Sell |
-24,424
| Closed | -$50K | – | 2351 |
|
|
2018
Q1 | $50K | Buy |
+24,424
| New | +$50K | ﹤0.01% | 1713 |
|
|
2017
Q4 | – | Sell |
-32,337
| Closed | -$170K | – | 2813 |
|
|
2017
Q3 | $170K | Buy |
+32,337
| New | +$170K | 0.01% | 1920 |
|